Federation des caisses Desjardins du Quebec’s Acadia Pharmaceuticals ACAD Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.86K	Buy	+129	New	+$3.08K	﹤0.01%	2612
2021 Q3	–	Sell	-229	Closed	-$5.58K	–	2550
2021 Q2	$5.58K	Hold	229	–	–	﹤0.01%	2201
2021 Q1	$5.91K	Buy	+229	New	+$10.1K	﹤0.01%	2153

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ACAD Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Acadia Pharmaceuticals (ACAD) in Q1 2026: 129 shares worth $2.86K. The stake represents ﹤0.01% of the portfolio and ranks #2612 among its holdings. This is a return to the name: Federation des caisses Desjardins du Quebec previously reported a position in ACAD as recently as Q2 2021.

Federation des caisses Desjardins du Quebec first reported a position in ACAD in Q1 2021 and has held it in 3 quarters since. The position peaked at $5.91K in Q1 2021. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

Federation des caisses Desjardins du Quebec held 129 shares of Acadia Pharmaceuticals worth $2.86K as of Q1 2026.
Acadia Pharmaceuticals was a new Federation des caisses Desjardins du Quebec position in Q1 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2612 holding.
Federation des caisses Desjardins du Quebec first reported a position in Acadia Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
Federation des caisses Desjardins du Quebec's Acadia Pharmaceuticals position peaked at $5.91K in Q1 2021.
340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.